Alison K. Conlin, MD, discusses the practice-changing data of fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer.
Practical Approaches to Treatment in Patients with Breast Cancer
Virginia G. Kaklamani, MD, discusses the use of adjuvant olaparib in germline BRCA1/2-mutant breast cancer.
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Data Refine the Role of Immunotherapy Across Early-Stage NSCLC Settings
2
Dr Tarantino on the Evolution of TROP2-Directed ADCs in First-Line TNBC
3
Dr Hurvitz on Updated PFS Data From the SERENA-6 Trial in Breast Cancer
4
Ris-Rez Meets Phase 3 Efficacy End Point for R/R Osteosarcoma
5